|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zhang S and Zou X: Estimation and
projection of lung cancer incidence and mortality in China.
Zhongguo Fei Ai Za Zhi. 13:488–493. 2010.(In Chinese). PubMed/NCBI
|
|
4
|
Robinson KW and Sandler AB: The role of
MET receptor tyrosine kinase in non-small cell lung cancer and
clinical development of targeted anti-MET agents. Oncologist.
18:115–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosell R and Karachaliou N: Lung cancer:
Maintenance therapy and precision medicine in NSCLC. Nat Rev Clin
Oncol. 10:549–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working
Group, : Recent cancer survival in Europe: A 2000-02 period
analysis of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gal A, Sjöblom T, Fedorova L, Imreh S,
Beug H and Moustakas A: Sustained TGF beta exposure suppresses Smad
and non-Smad signalling in mammary epithelial cells, leading to EMT
and inhibition of growth arrest and apoptosis. Oncogene.
27:1218–1230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding X, Park SI, McCauley LK and Wang CY:
Signaling between transforming growth factor β (TGF-β) and
transcription factor SNAI2 represses expression of microRNA miR-203
to promote epithelial-mesenchymal transition and tumor metastasis.
J Biol Chem. 288:10241–10253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moustakas A and Heldin CH: Signaling
networks guiding epithelial-mesenchymal transitions during
embryogenesis and cancer progression. Cancer Sci. 98:1512–1520.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J,
Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L and Chen XF:
Transforming growth factor-β1 promotes lung adenocarcinoma invasion
and metastasis by epithelial-to-mesenchymal transition. Mol Cell
Biochem. 355:309–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang H, Wang L, Zhao J, Chen Y, Lei Z, Liu
X, Xia W, Guo L and Zhang HT: TGF-β-activated SMAD3/4 complex
transcriptionally upregulates N-cadherin expression in non-small
cell lung cancer. Lung Cancer. 87:249–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Millet C and Zhang YE: Roles of Smad3 in
TGF-beta signaling during carcinogenesis. Crit Rev Eukaryot Gene
Expr. 17:281–293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Attisano L and Wrana JL: Signal
transduction by the TGF-beta superfamily. Science. 296:1646–1647.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang G and Yang X: Smad4-mediated TGF-beta
signaling in tumorigenesis. Int J Biol Sci. 6:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Levy L and Hill CS: Alterations in
components of the TGF-beta superfamily signaling pathways in human
cancer. Cytokine Growth Factor Rev. 17:41–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roberts AB, Tian F, Byfield SD, Stuelten
C, Ooshima A, Saika S and Flanders KC: Smad3 is key to
TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,
tumor suppression and metastasis. Cytokine Growth Factor Rev.
17:19–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu
M, Feng XH, Sawaya R, Medema RH, Hung MC and Huang S: Sustained
activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer
metastasis. J Clin Invest. 124:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vincent T, Neve EP, Johnson JR, Kukalev A,
Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL,
et al: A SNAIL1-SMAD3/4 transcriptional repressor complex promotes
TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol.
11:943–950. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang H, Sun P, Lei Z, Li M, Wang Y, Zhang
HT and Liu J: miR-145 inhibits invasion and metastasis by directly
targeting Smad3 in nasopharyngeal cancer. Tumour Biol.
36:4123–4131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao W, Zou J, Wang B, Fan P, Mao J, Li J,
Liu H, Xiao J, Ma W, Wang M, et al: microRNA-140 suppresses the
migration and invasion of colorectal cancer cells through targeting
Smad3. Zhonghua Zhong Liu Za Zhi. 36:739–745. 2014.(In Chinese).
PubMed/NCBI
|
|
24
|
Huang S, Wu S, Ding J, Lin J, Wei L, Gu J
and He X: MicroRNA-181a modulates gene expression of zinc finger
family members by directly targeting their coding regions. Nucleic
Acids Res. 38:7211–7218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen K and Rajewsky N: Natural selection
on human microRNA binding sites inferred from SNP data. Nat Genet.
38:1452–1456. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang C, Wang X, Liang H, Wang T, Yan X,
Cao M, Wang N, Zhang S, Zen K, Zhang C and Chen X: miR-203 inhibits
cell proliferation and migration of lung cancer cells by targeting
PKCα. PLoS One. 8:e739852013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider MR: MicroRNAs as novel players
in skin development, homeostasis and disease. Br J Dermatol.
166:22–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Butz H, Rácz K, Hunyady L and Patócs A:
Crosstalk between TGF-β signaling and the microRNA machinery.
Trends Pharmacol Sci. 33:382–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen T, Xu C, Chen J, Ding C, Xu Z, Li C
and Zhao J: MicroRNA-203 inhibits cellular proliferation and
invasion by targeting Bmi1 in non-small cell lung cancer. Oncol
Lett. 9:2639–2646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang N, Liang H, Zhou Y, Wang C, Zhang S,
Pan Y, Wang Y, Yan X, Zhang J, Zhang CY, et al: miR-203 suppresses
the proliferation and migration and promotes the apoptosis of lung
cancer cells by targeting SRC. PLoS One. 9:e1055702014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dickie LJ, Aziz AM, Savic S, Lucherini OM,
Cantarini L, Geiler J, Wong CH, Coughlan R, Lane T, Lachmann HJ, et
al: Involvement of X-box binding protein 1 and reactive oxygen
species pathways in the pathogenesis of tumour necrosis factor
receptor-associated periodic syndrome. Ann Rheum Dis. 71:2035–2043.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yauch RL, Januario T, Eberhard DA, Cavet
G, Zhu W, Fu L, Pham TQ, Soriano R, Stinson J, Seshagiri S, et al:
Epithelial versus mesenchymal phenotype determines in vitro
sensitivity and predicts clinical activity of erlotinib in lung
cancer patients. Clin Cancer Res. 11:8686–8698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shintani Y, Okimura A, Sato K, Nakagiri T,
Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et
al: Epithelial to mesenchymal transition is a determinant of
sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann
Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung JW, Hwang SY, Hwang JS, Oh ES, Park S
and Han IO: Ionising radiation induces changes associated with
epithelial-mesenchymal transdifferentiation and increased cell
motility of A549 lung epithelial cells. Eur J Cancer. 43:1214–1224.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou YC, Liu JY, Li J, Zhang J, Xu YQ,
Zhang HW, Qiu LB, Ding GR, Su XM, Mei-Shi and Guo GZ: Ionizing
radiation promotes migration and invasion of cancer cells through
transforming growth factor-beta-mediated epithelial-mesenchymal
transition. Int J Radiat Oncol Biol Phys. 81:1530–1537. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Theys J, Jutten B, Habets R, Paesmans K,
Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M:
E-Cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Derynck R and Akhurst RJ: Differentiation
plasticity regulated by TGF-beta family proteins in development and
disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Yang H, Lei Z, Zhao J, Chen Y,
Chen P, Li C, Zeng Y, Liu Z, Liu X and Zhang HT: Repression of
TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal
transition in non-small-cell lung cancer. Oncogene. 35:867–877.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cho HJ, Baek KE, Saika S, Jeong MJ and Yoo
J: Snail is required for transforming growth factor-beta-induced
epithelial-mesenchymal transition by activating PI3 kinase/Akt
signal pathway. Biochem Biophys Res Commun. 353:337–343. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shintani Y, Maeda M, Chaika N, Johnson KR
and Wheelock MJ: Collagen I promotes epithelial-to-mesenchymal
transition in lung cancer cells via transforming growth factor-beta
signaling. Am J Respir Cell Mol Biol. 38:95–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bruna A, Darken RS, Rojo F, Ocaña A,
Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J and
Seoane J: High TGFbeta-Smad activity confers poor prognosis in
glioma patients and promotes cell proliferation depending on the
methylation of the PDGF-B gene. Cancer Cell. 11:147–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu
Z, Zhao J and Zhang HT: JAK/STAT3 signaling is required for
TGF-β-induced epithelial-mesenchymal transition in lung cancer
cells. Int J Oncol. 44:1643–1651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang C, Song X, Li Y, Han F, Gao S, Wang
X, Xie S and Lv C: Low-dose paclitaxel ameliorates pulmonary
fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140
upregulation. PLoS One. 8:e707252013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cao H, Yang CS and Rana TM: Evolutionary
emergence of microRNAs in human embryonic stem cells. PLoS One.
3:e28202008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Krichevsky AM, King KS, Donahue CP,
Khrapko K and Kosik KS: A microRNA array reveals extensive
regulation of microRNAs during brain development. RNA. 9:1274–1281.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakayama K, Nakayama N, Katagiri H and
Miyazaki K: Mechanisms of ovarian cancer metastasis: Biochemical
pathways. Int J Mol Sci. 13:11705–11717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cuesta R, Martínez-Sánchez A and Gebauer
F: miR-181a regulates cap-dependent translation of p27(kip1) mRNA
in myeloid cells. Mol Cell Biol. 29:2841–2851. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan
YH, Xu ZM and Yin YB: Microarray analysis of microRNA expression in
peripheral blood cells of systemic lupus erythematosus patients.
Lupus. 16:939–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Abella V, Valladares M, Rodriguez T, Haz
M, Blanco M, Tarrío N, Iglesias P, Aparicio LA and Figueroa A:
miR-203 regulates cell proliferation through its influence on Hakai
expression. PLoS One. 7:e525682012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou Y, Liang H, Liao Z, Wang Y, Hu X,
Chen X, Xu L and Hu Z: miR-203 enhances let-7 biogenesis by
targeting LIN28B to suppress tumor growth in lung cancer. Sci Rep.
7:426802017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang Y, Liu L, Cai J, Wu J, Guan H, Zhu X,
Yuan J, Chen S and Li M: Targeting Smad2 and Smad3 by miR-136
suppresses metastasis-associated traits of lung adenocarcinoma
cells. Oncol Res. 21:345–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y,
Liu Z and Gou S: MicroRNA-323-3p inhibits cell invasion and
metastasis in pancreatic ductal adenocarcinoma via direct
suppression of SMAD2 and SMAD3. Oncotarget. 7:14912–14924.
2016.PubMed/NCBI
|
